Predictive Score of Risk Associated with Progression of Patients with COVID-19 Pneumonia in Wuhan, China: the ALA Score

被引:9
作者
Wang, Menghan [1 ]
Yu, Dongping [1 ]
Shang, Yu [2 ]
Zhang, Xiaona [5 ]
Yang, Yi [1 ]
Zhao, Shuai [1 ]
Su, Dongju [1 ]
Liu, Lei [3 ]
Wang, Qin [4 ]
Ren, Juan [1 ]
Li, Yupeng [1 ]
Chen, Hong [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 2, Dept Resp & Crit Care Med, Harbin 150081, Peoples R China
[2] First Hosp Harbin, Dept Respirat, Harbin 150081, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, Dept Cadres Ward, Harbin 150081, Peoples R China
[4] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin 150081, Peoples R China
[5] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin 150081, Peoples R China
关键词
COVID-19; Wuhan; ALA score; Severe pneumonia; Risk factors;
D O I
10.1007/s13369-021-05808-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background The Coronavirus Disease 2019 (COVID-19) had become a Public Health Emergency of International Concern with more than 90 million confirmed cases worldwide. Therefore, this study aims to establish a predictive score model of progression to severe type in patients with COVID-19. Methods This is a retrospective cohort study of 151 patients with COVID-19 diagnosed by nucleic acid test or specific serum antibodies from February 13, 2020, to March 14, 2020, hospitalized in a COVID-19-designed hospital in Wuhan, China. Results Of the 151 patients with average age of 63 years, 64 patients were male (42.4%), and 29 patients (19.2%) were classified as severe group. Multivariate analysis showed that age > 65 years (odds ratio [OR] = 9.72, 95%CI: 2.92-32.31, P < 0.001), lymphocyte count <= 1.1 x 10(9)/L (OR = 3.42, 95%CI: 1.24-9.41, P = 0.017) and AST > 35 U/L (OR = 3.19, 95%CI: 1.11-9.19, P = 0.032) were independent risk factors for the disease severity. The area under curve (AUC) of receiver operating characteristic curve of the probabilities of the composite continuous variable (age + lymphocyte + AST) is 0.796. Finally, a predictive score model called ALA was established, and its AUC was 0.83 (95%CI: 0.75-0.92). Using a cutoff value of 9.5 points, the positive and negative predictive values were 54.1% (38-70.1%) and 92.1% (87.2-97.1%), respectively. Conclusion The ALA score model can quickly identify severe patients with COVID-19, so as to help clinicians to better choose accurate management strategy.
引用
收藏
页码:11029 / 11037
页数:9
相关论文
共 17 条
  • [1] [Anonymous], 2020, UPD NOV COR INF PNEU
  • [2] The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? - Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI)
    Biscayart, Cristian
    Angeleri, Patricia
    Lloveras, Susana
    Souza Chaves, Tania do Socorro
    Schlagenhauf, Patricia
    Rodriguez-Morales, Alfonso J.
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 33
  • [3] Chai X, 2020, bioRxiv, DOI [10.1101/2020.02.03.931766, 10.1101/2020.02.03.931766, 10.1101/2020.02.03.931766v1, DOI 10.1101/2020.02.03.931766]
  • [4] Huang CL, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, 10.1016/S0140-6736(20)30211-7]
  • [5] Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
    Lagunas-Rangel, Francisco Alejandro
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 1733 - 1734
  • [6] Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center
    Li, Yupeng
    Shang, Yu
    Yang, Yi
    Wang, Menghan
    Yu, Dongping
    Su, Dongju
    Liu, Lei
    Wang, Qin
    Zhang, Xiaona
    Ren, Juan
    Chen, Hong
    [J]. RESPIRATION, 2020, 99 (09) : 739 - 747
  • [7] Analysis of Epidemiological and Clinical Features in Older Patients With Coronavirus Disease 2019 (COVID-19) Outside Wuhan
    Lian, Jiangshan
    Jin, Xi
    Hao, Shaorui
    Cai, Huan
    Zhang, Shanyan
    Zheng, Lin
    Jia, Hongyu
    Hu, Jianhua
    Gao, Jianguo
    Zhang, Yimin
    Zhang, Xiaoli
    Yu, Guodong
    Wang, Xiaoyan
    Gu, Jueqing
    Ye, Chanyuan
    Jin, Ciliang
    Lu, Yingfeng
    Yu, Xia
    Yu, Xiaopeng
    Ren, Yue
    Qiu, Yunqing
    Li, Lanjuan
    Sheng, Jifang
    Yang, Yida
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) : 740 - 747
  • [8] National Institute for Viral Disease Control and Prevntion, 2020, SPEC PRIM PROB DET 2
  • [9] Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
    Qin, Chuan
    Zhou, Luoqi
    Hu, Ziwei
    Zhang, Shuoqi
    Yang, Sheng
    Tao, Yu
    Xie, Cuihong
    Ma, Ke
    Shang, Ke
    Wang, Wei
    Tian, Dai-Shi
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) : 762 - 768
  • [10] Towards better clinical prediction models: seven steps for development and an ABCD for validation
    Steyerberg, Ewout W.
    Vergouwe, Yvonne
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (29) : 1925 - +